Entering text into the input field will update the search result below

DiaMedica Therapeutics appoints chief medical officer

  • DiaMedica Therapeutics (NASDAQ:DMAC) appoints Kirsten Gruis, M.D. as Chief Medical Officer.
  • Dr. Gruis is a board-certified neurologist with 20 years of experience in both clinical medicine and drug development in large and small biopharmaceutical companies.
  • “We are delighted to welcome Dr. Gruis to the DiaMedica

Recommended For You

More Trending News

About DMAC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
DMAC--
DiaMedica Therapeutics Inc.